Contraceptive discontinuation rates in Nigeria vary widely by method type, from 7% to 59% within 12 months, driven primarily by side effects, fertility desires, and inadequate counseling. Addressing these determinants through improved provider training and client-centered care could meaningfully reduce unintended pregnancies in a country where modern contraceptive use remains low at 17-20%.
Researchers at the University of Nigeria conducted a systematic review examining why women stop using contraception despite ongoing need. They screened 12,768 records and included 48 studies to synthesize evidence on contraceptive discontinuation prevalence, patterns, and determinants among Nigerian women aged 15-49 years. Nigeria remains an important case study: the country's total fertility rate of 4.8 children per woman persists despite decades of family planning programs, in part because women who adopt contraception frequently abandon it.
The analysis revealed consistent patterns. Condoms showed discontinuation rates around 17-18% at 12 months, primarily driven by behavioral and perception-based factors: inconsistent use, discomfort during intercourse, and misconceptions about efficacy or necessity. Oral contraceptive pills had higher discontinuation, with 21-59% of users stopping within the first year. The main culprits were side effects (nausea, headaches, irregular bleeding), the daily regimen burden, and changes in fertility intentions. Injectable contraceptives fell in the middle with discontinuation rates of 19.8-53.3%, most occurring within the first 3-6 months, again triggered by side effects and desire for pregnancy.
Long-acting reversible contraceptives (LARCs), including implants and intrauterine devices, showed the lowest discontinuation rates overall: 7% to 42.9% at 12 months. However, early discontinuation was still significant and linked to menstrual irregularities, want of pregnancy, and method-specific adverse effects. The consistent finding across all methods was that LARCs required less frequent decision-making and consequently experienced fewer dropout points compared to user-dependent methods.
Beyond pharmacological and physiological factors, the review identified critical social and structural determinants. Spousal opposition emerged as a major barrier in a cultural context where family planning decisions often require male partner approval. Cultural and religious beliefs, particularly in communities where large family sizes carry social value, actively discouraged continued use. Poor-quality counseling at the point of service was particularly damaging: women reported insufficient information about what side effects to expect, how long they might persist, and what alternatives existed. This counseling gap meant that when inevitable side effects occurred, women had no framework to contextualize them and often assumed the method was unsuitable rather than a normal, manageable response.
This systematic review does not make direct health claims about contraceptive methods. Instead, it documents a real-world implementation problem: women in Nigeria adopt contraception at low rates, and those who do often discontinue it. The findings point to modifiable factors that health systems can address.
If you are a policymaker or healthcare provider in settings with similar characteristics to Nigeria, the evidence suggests that improving contraceptive outcomes requires more than supply and availability. Provider training in side effect management, patient counseling quality, and follow-up systems matter. Client-centered approaches that explore fertility intentions, address concerns about specific methods, and involve male partners or community figures appear necessary.
If you are a woman considering contraception, this review underscores the importance of realistic expectations and informed choice. Different methods have different discontinuation profiles not because they are inherently flawed, but because they match differently with individual circumstances. A method with lower overall discontinuation (like an IUD or implant) might be right for you if you want multi-year protection without thinking about it daily. Daily methods require stronger commitment but offer faster reversibility if circumstances change. Discontinuation often happens early: 3-6 months for injectables, within 12 months for pills. If you experience side effects, discussion with your provider about timing, management strategies, or alternatives is warranted rather than immediate cessation.
The review also highlights that male partner support and community attitudes matter significantly. Family planning conversations that include partners or address cultural concerns may improve sustained use.
| Attribute | Detail |
|---|---|
| Study type | Systematic review of observational, qualitative, and mixed-methods studies |
| Records screened | 12,768 |
| Studies included | 48 |
| Population | Sexually active women aged 15-49 years in Nigeria with prior contraceptive use |
| Geographic focus | Nigeria |
| Outcomes measured | Contraceptive discontinuation prevalence, method-specific discontinuation patterns, reasons for cessation |
| Main determinants identified | Side effects, fertility intentions, spousal opposition, cultural/religious beliefs, poor counseling quality |
| Publication journal | BMC Public Health |
| PubMed ID | 42443807 |
Determinants of contraceptive discontinuation among sexually active women in Nigeria: a systematic review. BMC Public Health. PubMed: 42443807
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.